LNA Santé SA (0OR2.L)

EUR 22.7

(0.0%)

EBITDA Summary of LNA Santé SA

  • LNA Santé SA's latest annual EBITDA in 2023 was 144.63 Million EUR , down -0.59% from previous year.
  • LNA Santé SA's latest quarterly EBITDA in 2024 Q2 was 44.3 Million EUR , down 0.0% from previous quarter.
  • LNA Santé SA reported an annual EBITDA of 141.82 Million EUR in 2022, up 6.32% from previous year.
  • LNA Santé SA reported an annual EBITDA of 131.64 Million EUR in 2021, up 18.38% from previous year.
  • LNA Santé SA reported a quarterly EBITDA of 42.62 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • LNA Santé SA reported a quarterly EBITDA of N/A for 2023 FY, down -0.59% from previous quarter.

Annual EBITDA Chart of LNA Santé SA (2023 - 2009)

Historical Annual EBITDA of LNA Santé SA (2023 - 2009)

Year EBITDA EBITDA Growth
2023 144.63 Million EUR -0.59%
2022 141.82 Million EUR 6.32%
2021 131.64 Million EUR 18.38%
2020 108.16 Million EUR 3.5%
2019 112.47 Million EUR 114.99%
2018 50.47 Million EUR 2.13%
2017 46.09 Million EUR 8.85%
2016 45.52 Million EUR 7.32%
2015 40.01 Million EUR -2.34%
2014 45.92 Million EUR 27.13%
2013 35.61 Million EUR 50.87%
2012 25.31 Million EUR 8.79%
2011 23.96 Million EUR -2.34%
2010 22.22 Million EUR 12.02%
2009 19.91 Million EUR 0.0%

Peer EBITDA Comparison of LNA Santé SA

Name EBITDA EBITDA Difference
Cegedim SA 95.25 Million EUR -51.846%
Guerbet SA 90.09 Million EUR -60.538%
Nexus AG 53.43 Million EUR -170.695%
Bastide Le Confort Médical SA 110.32 Million EUR -31.1%
Revenio Group Oyj 30.09 Million EUR -380.675%
Drägerwerk AG & Co. KGaA 318.33 Million EUR 54.565%
Sartorius Aktiengesellschaft 811.2 Million EUR 82.17%
Siemens Healthineers AG 4.22 Billion EUR 96.577%
Medios AG 52.81 Million EUR -173.847%
Equasens Société anonyme 71.29 Million EUR -102.857%
Stratec SE 39.82 Million EUR -263.213%